Protect Pharmaceutical Corporation
Protect Pharmaceutical Corporation primarily focuses on crop farming and agricultural businesses. It acquires the Can Noguera property located in Selva Girona region in Spain. Its property consists of 60 hectares of arable land, 390 hectares of forests, 6 mineral and freshwater wells, and 3000 square meters of built properties. The company was formerly known as Pro-Tect, Inc. and changed its name… Read more
Protect Pharmaceutical Corporation (PRTT) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2025: -0.006x
Based on the latest financial reports, Protect Pharmaceutical Corporation (PRTT) has a cash flow conversion efficiency ratio of -0.006x as of June 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-2.10 Million) by net assets ($345.88 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Protect Pharmaceutical Corporation - Cash Flow Conversion Efficiency Trend (2011–2024)
This chart illustrates how Protect Pharmaceutical Corporation's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Protect Pharmaceutical Corporation Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Protect Pharmaceutical Corporation ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
CATENON SA INH. EO-02
F:8Y9
|
N/A |
|
BLUE STAR GOLD
F:5WP0
|
N/A |
|
Tiny Ltd.
PINK:TNYZF
|
0.064x |
|
Ayalon Holdings Ltd
TA:AYAL
|
-0.012x |
|
Acceleware Ltd
PINK:ACWRF
|
0.055x |
|
Lippo General Insurance Tbk
JK:LPGI
|
0.084x |
|
Canaf Investments Inc
PINK:CAFZF
|
0.057x |
|
Keyware Technologies NV
BR:KEYW
|
0.016x |
Annual Cash Flow Conversion Efficiency for Protect Pharmaceutical Corporation (2011–2024)
The table below shows the annual cash flow conversion efficiency of Protect Pharmaceutical Corporation from 2011 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $332.69 Million | $12.71 Million | 0.038x | +161.27% |
| 2023-12-31 | $276.36 Million | $4.04 Million | 0.015x | +105.01% |
| 2022-12-31 | $229.98 Million | $-67.20 Million | -0.292x | -671.98% |
| 2021-12-31 | $205.64 Million | $10.51 Million | 0.051x | -95.56% |
| 2020-12-31 | $5.89 Million | $6.77 Million | 1.150x | +635.98% |
| 2019-12-31 | $76.62K | $11.97K | 0.156x | -78.26% |
| 2018-12-31 | $-50.19K | $-36.09K | 0.719x | -- |
| 2017-12-31 | $-143.44K | $0.00 | 0.000x | -- |
| 2016-12-31 | $-20.83K | $-14.16K | 0.680x | +283.45% |
| 2015-12-31 | $-100.45K | $-17.80K | 0.177x | +11880.54% |
| 2014-12-31 | $-120.98K | $-179.00 | 0.001x | +391.91% |
| 2013-12-31 | $-595.13K | $-179.00 | 0.000x | -99.19% |
| 2012-12-31 | $-577.19K | $-21.41K | 0.037x | +171.20% |
| 2011-12-31 | $-425.56K | $22.17K | -0.052x | -- |